Fifth Third Bancorp’s Lisata Therapeutics LSTA Stock Holding History

Fifth Third Bancorp’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-67	Closed	-$3K	–	2282
2019 Q3	$3K	Hold	67	–	–	﹤0.01%	2001
2019 Q2	$2K	Hold	67	–	–	﹤0.01%	2145
2019 Q1	$4K	Hold	67	–	–	﹤0.01%	1976
2018 Q4	$4K	Hold	67	–	–	﹤0.01%	2008
2018 Q3	$6K	Hold	67	–	–	﹤0.01%	1947
2018 Q2	$6K	Hold	67	–	–	﹤0.01%	2004
2018 Q1	$6K	Hold	67	–	–	﹤0.01%	2020
2017 Q4	$4K	Hold	67	–	–	﹤0.01%	2038
2017 Q3	$4K	Hold	67	–	–	﹤0.01%	1961
2017 Q2	$5K	Hold	67	–	–	﹤0.01%	1905
2017 Q1	$5K	Hold	67	–	–	﹤0.01%	1846
2016 Q4	$3K	Hold	67	–	–	﹤0.01%	2003
2016 Q3	$5K	Hold	67	–	–	﹤0.01%	1975
2016 Q2	$6K	Hold	67	–	–	﹤0.01%	1938
2016 Q1	$8K	Hold	67	–	–	﹤0.01%	1911
2015 Q4	$11K	Hold	67	–	–	﹤0.01%	1915
2015 Q3	$15K	Sell	67 -3	-4%	-$753	﹤0.01%	1857
2015 Q2	$20K	Buy	70 +57	+438%	+$21.2K	﹤0.01%	1811
2015 Q1	$5K	Buy	+13	New	+$7.05K	﹤0.01%	2222

Other funds holding LSTA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

WesBanco Bank Wheeling, West Virginia $3.61B AUM 24.09% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Fifth Third Bancorp's LSTA Position: Q4 2019 in Review

Fifth Third Bancorp sold out of Lisata Therapeutics (LSTA) in Q4 2019, closing a stake of 67 shares — an estimated $3K sold.

Fifth Third Bancorp first reported a position in LSTA in Q1 2015 and held it in 19 quarters. The position peaked at $20K in Q2 2015. 23 funds tracked by Wall St. Rank hold LSTA as of Q4 2019.

Fifth Third Bancorp reported no remaining Lisata Therapeutics position as of Q4 2019 after selling out during the quarter.
Fifth Third Bancorp sold 67 Lisata Therapeutics shares in Q4 2019, an estimated $3K.
Fifth Third Bancorp first reported a position in Lisata Therapeutics in Q1 2015 and held it in 19 quarters.
Fifth Third Bancorp's Lisata Therapeutics position peaked at $20K in Q2 2015.
23 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q4 2019.

Based on Fifth Third Bancorp's 13F filing for Q4 2019, filed 14 Feb 2020.